Carbon monoxide-releasing molecule-3 protects against ischemic stroke by suppressing neuroinflammation and alleviating blood-brain barrier disruption.
Carbon monoxide-releasing molecule-3 protects against ischemic stroke by suppressing neuroinflammation and alleviating blood-brain barrier disruption.
复制标题
一氧化碳释放分子 3 通过抑制神经炎症和减轻血脑屏障破坏来预防缺血性中风
DOI:
10.1186/s12974-018-1226-1
复制
发表时间:
2018-06-21
影响因子:
9.3
通讯作者:
Wang J
中科院分区:
文献类型:
--
作者:
Wang J;Zhang D;Fu X;Yu L;Lu Z;Gao Y;Liu X;Man J;Li S;Li N;Chen X;Hong M;Yang Q;Wang J
BackgroundAt low levels, carbon monoxide (CO) has been shown to have beneficial effects on multiple organs and tissues through its potential anti-inflammatory, anti-apoptotic, and anti-proliferative properties. However, the effect of CO-releasing molecule (CORM)-3, a water-soluble CORM, on ischemic stroke and its mechanism of action are still unclear.MethodsWe investigated the role of CORM-3 in the mouse model of transient middle cerebral artery occlusion (tMCAO). CORM-3 or saline was administered to mice by retro-orbital injection at the time of reperfusion after 1-h tMCAO or at 1 h after sham surgery. We assessed infarct volume and brain water content at 24 and 72 h after ischemia, blood-brain barrier permeability at 6 and 72 h after ischemia, and neurologic deficits on days 1, 3, 7, and 14.ResultsAmong mice that underwent tMCAO, those that received CORM-3 had significantly smaller infarct volume and greater expression of neuronal nuclear antigen (NeuN) and microtubule-associated protein 2 than did saline-treated mice. CORM-3-treated mice had significantly fewer activated microglia in the peri-infarction zone than did control mice and exhibited downregulated expression of ionized calcium-binding adapter molecule (Iba)-1, tumor necrosis factor-α, and interleukin 1β. CORM-3-treated mice had significantly lower brain water content and enhanced neurologic outcomes on days 3, 7, and 14 post-tMCAO. Lastly, CORM-3 treatment reduced Evans blue leakage; increased expression of platelet-derived growth factor receptor-β, tight junction protein ZO-1, and matrix protein laminin; and decreased protein level of matrix metalloproteinase-9.ConclusionCORM-3 treatment at the time of reperfusion reduces ischemia-reperfusion-induced brain injury by suppressing neuroinflammation and alleviating blood-brain barrier disruption. Our data suggest that CORM-3 may provide an effective therapy for ischemic stroke.
登录
查看更多内容
影响因子:
6.1
作者:
Li Q;Han X;Lan X;Hong X;Li Q;Gao Y;Luo T;Yang Q;Koehler RC;Zhai Y;Zhou J;Wang J
通讯作者:
Wang J
影响因子:
29.7
作者:
Nayak D;Roth TL;McGavern DB
通讯作者:
McGavern DB
影响因子:
6.3
作者:
Li, Qian;Wan, Jieru;Wang, Jian
通讯作者:
Wang, Jian
影响因子:
7.2
作者:
Ginhoux, Florent;Prinz, Marco
通讯作者:
Prinz, Marco
影响因子:
7.4
作者:
Cheng T;Wang W;Li Q;Han X;Xing J;Qi C;Lan X;Wan J;Potts A;Guan F;Wang J
通讯作者:
Wang J